Bedrijfsoverzicht
EUDA Health Holdings Limited is a specialized entity focused on the provision of non-invasive healthcare services, with a primary operational footprint in Singapore, Malaysia, and China. The company's portfolio includes the delivery of bioenergy capsule therapies, stem cell treatments, CRISPR gene editing services, as well as the sale of supplements and property management solutions. This business model places the firm squarely within the Real Estate sector, specifically under the Real Estate Services industry classification. In terms of scale, the company maintains a market capitalization of $12.70M while generating $5.16M in annual revenue, supported by a workforce of 117 employees. These valuation and revenue figures indicate that EUDA operates as a mid-cap entity with a relatively modest revenue base, suggesting a company that is likely still in a phase of scaling or niche market consolidation rather than established large-cap dominance.
Financiële gezondheid
The company reported a revenue of $5.16M over the trailing twelve months, yet this generated a net income of $-2,064,341, revealing a significant structural cost burden where expenses substantially exceed profit margins. The EBITDA stands at $-1,992,526, further highlighting the aggressive cost structure or heavy investment requirements inherent in its healthcare service delivery model. Consequently, the company reports a free cash flow of $-3,350,164, which indicates a lack of financial flexibility and a reliance on external capital to fund operations rather than organic cash generation. Margin analysis shows a gross margin of 22.4%, which is acceptable for service-oriented businesses but is severely eroded by operating expenses, resulting in an operating margin of -37.0%. Despite the negative operating performance, the profit margin is listed as 5.2%, a metric that appears inconsistent with the negative net income and requires careful interpretation regarding non-recurring items or accounting adjustments. The balance sheet presents a complex picture with $176,584 in cash assets offset against $2.28M in debt, while the debt-to-equity ratio is marked as N/A. The current ratio of 0.23 signals a precarious short-term liquidity position, indicating that current assets are less than half of current liabilities. Furthermore, the return on equity is N/A due to the negative equity structure, while the return on assets stands at -63.9%, demonstrating that management is currently destroying value relative to the asset base employed.
Waarderingsbeoordeling
Valuation metrics present a stark contrast between historical and future expectations, with a trailing P/E ratio of 16.80 and a forward P/E of 4.20. This substantial divergence implies that the market expects a dramatic turnaround in earnings, driving the forward multiple significantly lower than the historical average despite current losses. The price-to-book ratio is recorded at -3.37, indicating that the stock trades at a negative multiple relative to book value, a situation typical for companies with accumulated deficits or impaired assets. Alternative valuation measures such as the price-to-sales ratio of 2.46 and an EV/EBITDA of -7.32 suggest that the market is pricing the company based on sales potential and enterprise value rather than current profitability. In terms of trading range, the 52-week high is $86.00 and the 52-week low is $6.42, placing the current market price in a context where it could theoretically trade up to approximately 92% below the recent high or down to approximately 92% above the recent low, depending on the specific price point. The stock exhibits a beta of 0.16, which signifies that its price volatility is significantly lower than the broader market, making it a low-volatility asset within the real estate services sector.
Growth & Income
Revenue growth for the year-over-year period is 60.2%, demonstrating a robust expansion in top-line sales, whereas earnings growth is listed as N/A due to the negative net income position. Since the company is currently unprofitable with a net loss, it cannot sustain a dividend payout, resulting in a dividend yield of N/A and a payout ratio of 0.0%. This zero payout ratio is not a choice to conserve cash but a necessity, as the firm must reinvest all available resources and potentially raise capital to cover its operating losses and debt obligations. The overall growth and income profile is characterized by strong revenue acceleration coupled with significant earnings drag, offering no immediate income stream but highlighting the high risk and high reward nature of its expansion strategy.